Simone Kayser

817 total citations
16 papers, 578 citations indexed

About

Simone Kayser is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Simone Kayser has authored 16 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Simone Kayser's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Simone Kayser is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Simone Kayser collaborates with scholars based in Germany, United States and Switzerland. Simone Kayser's co-authors include Tobias Feuchtinger, Rupert Handgretinger, Peter Lang, Stefan Stevanović, Johann Greil, Wolfgang Bethge, Michael H. Albert, Judith Feucht, Christina Kyzirakos and Michael Schumm and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Simone Kayser

16 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Kayser Germany 10 394 264 180 130 89 16 578
Aisha Hasan United States 14 367 0.9× 257 1.0× 226 1.3× 136 1.0× 45 0.5× 55 696
Clare Taylor United States 8 751 1.9× 356 1.3× 204 1.1× 201 1.5× 133 1.5× 15 942
Renate de Boer Netherlands 16 576 1.5× 654 2.5× 167 0.9× 199 1.5× 65 0.7× 30 1.1k
Jerill Thorpe United States 12 227 0.6× 244 0.9× 164 0.9× 267 2.1× 78 0.9× 23 740
Marie Roskrow Germany 14 546 1.4× 513 1.9× 174 1.0× 129 1.0× 173 1.9× 24 873
Kitsada Wudhikarn Thailand 14 541 1.4× 144 0.5× 49 0.3× 125 1.0× 136 1.5× 55 742
Stephanie Ku United States 5 454 1.2× 395 1.5× 96 0.5× 117 0.9× 213 2.4× 8 660
Eliana Ruggiero Italy 13 275 0.7× 372 1.4× 98 0.5× 94 0.7× 27 0.3× 28 629
Vicky Torrano United States 6 791 2.0× 389 1.5× 109 0.6× 187 1.4× 273 3.1× 9 893
Brian H. Santich United States 12 164 0.4× 390 1.5× 61 0.3× 67 0.5× 49 0.6× 19 722

Countries citing papers authored by Simone Kayser

Since Specialization
Citations

This map shows the geographic impact of Simone Kayser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Kayser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Kayser more than expected).

Fields of papers citing papers by Simone Kayser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Kayser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Kayser. The network helps show where Simone Kayser may publish in the future.

Co-authorship network of co-authors of Simone Kayser

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Kayser. A scholar is included among the top collaborators of Simone Kayser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Kayser. Simone Kayser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zelba, Henning, Christina Kyzirakos, Simone Kayser, et al.. (2024). Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy. Vaccines. 12(4). 397–397. 1 indexed citations
3.
Zelba, Henning, Armin Rabsteyn, Oliver Bartsch, et al.. (2022). Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination—A Retrospective Observation. Vaccines. 10(11). 1882–1882. 7 indexed citations
5.
Zelba, Henning, Johannes Harter, Natalia Pieper, et al.. (2020). A Highly Specific Assay for the Detection of SARS-CoV-2–Reactive CD4+ and CD8+ T Cells in COVID-19 Patients. The Journal of Immunology. 206(3). 580–587. 13 indexed citations
6.
Feucht, Judith, Simone Kayser, Mohamad Hamieh, et al.. (2016). T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts. Oncotarget. 7(47). 76902–76919. 137 indexed citations
7.
Kayser, Simone, Judith Feucht, Stefan Stevanović, et al.. (2015). Rapid generation of NY-ESO-1-specific CD4+THELPER1 cells for adoptive T-cell therapy. OncoImmunology. 4(5). e1002723–e1002723. 16 indexed citations
8.
Günther, Patrick, Janet K. Peper-Gabriel, Simone Kayser, et al.. (2015). Identification of a Novel Immunodominant HLA-B*07. Journal of Immunotherapy. 38(7). 267–275. 10 indexed citations
9.
Feucht, Judith, Kathrin Opherk, Peter Lang, et al.. (2015). Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. Blood. 125(12). 1986–1994. 99 indexed citations
10.
Feuchtinger, Tobias, Judith Feucht, Simone Kayser, et al.. (2015). Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab. Blood. 126(23). 3764–3764. 1 indexed citations
11.
Leibold, Josef, Judith Feucht, Stefan Stevanović, et al.. (2012). Induction of Thelper1-driven Antiviral T-cell Lines for Adoptive Immunotherapy Is Determined by Differential Expression of IFN-γ and T-cell Activation Markers. Journal of Immunotherapy. 35(9). 661–669. 6 indexed citations
12.
Icheva, Vanya, Simone Kayser, Daniel Wolff, et al.. (2012). Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation. Journal of Clinical Oncology. 31(1). 39–48. 198 indexed citations
13.
Icheva, Vanya, Kathrin Opherk, Wolfgang Bethge, et al.. (2010). Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation. Blood. 116(21). 2342–2342. 2 indexed citations
14.
Gückel, Brigitte, Christine Rentzsch, Maria-Dorothea Nastke, et al.. (2005). Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers. Journal of Cancer Research and Clinical Oncology. 132(4). 265–274. 16 indexed citations
15.
Rentzsch, Christine, Simone Kayser, Steffen Walter, et al.. (2003). Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.. PubMed. 9(12). 4376–86. 44 indexed citations
16.
Rentzsch, Christine, et al.. (2003). Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition?. Journal of Cancer Research and Clinical Oncology. 129(7). 397–409. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026